我省加强药品质量“守门员”管理

Core Points - Shandong Province has revised the "Management Measures for Drug Quality Authorizers" to enhance drug safety by establishing clear responsibilities for a "Chief Quality Officer" within pharmaceutical companies [2][3] - The new regulations will take effect on December 1, requiring drug quality authorizers to be full-time senior management personnel with professional backgrounds and practical experience [2] - The authorizers are responsible for the quality evaluation of each batch of drugs, and no drug can be released without their approval [2] Summary by Sections Regulatory Changes - The revised measures detail the responsibilities and qualifications of drug quality authorizers, emphasizing the need for their independence from interference by other company officials [2] - Companies must improve their drug quality authorizer systems and complete personnel appointments before the new regulations come into effect [2] Responsibilities and Rights - Drug quality authorizers must have access to all information related to product quality, including raw material procurement and production processes [2] - The regulations outline penalties for companies that fail to comply, including warnings, interviews, deadlines for rectification, and potential suspension of production and sales [2] Impact on Industry - Experts note that the previous version of the regulations has significantly strengthened drug production supervision and quality assurance systems since its implementation in 2020 [3] - The revised regulations are expected to further enforce corporate responsibility for drug safety, adding an additional layer of protection for public health in Shandong [3]